Results 1 to 10 of about 85,022 (329)
Frontiers in Oncology, 2023 Lymphoblastic lymphoma (LBL) is a rare tumor that accounts for approximately 2-4% of all non-Hodgkin lymphomas, and less than 20% of LBLs are derived from B cells.
Yi Wang +8 more
doaj +1 more source
Case Reports in Hematology, 2022 Treatment of early relapses of T lymphoblastic leukemia/lymphoma is often unsuccessful. We tested an experimental regimen containing daratumumab and nelarabine in two young patients with early relapses of T lymphoblastic lymphoma and T-ALL, respectively.
Ingolf Molle +3 more
doaj +1 more source
Diagnostics, 2022 Primary soft-tissue lymphoma (PSTL) is a rare extranodal non-Hodgkin lymphoma, characterized by a mass growing within soft-tissue, which is connective tissue, adipose tissue, and skeletal muscle.
Giulia A. Restivo +8 more
doaj +1 more source
The chemotherapy of lymphoblastic lymphoma [PDF]
Blood, 1981 Abstract Thirty-two patients treated on consecutive Southwest Oncology Group (SWOG) protocols for malignant lymphoma were subsequently diagnosed as having lymphoblastic lymphoma. Combination chemistry, usually adriamycin-based, produced complete responses (CR) in 17 patients (53%). Median survival was 15 mo.
Eugene M. McKelvey +5 more
openaire +4 more sources
Lymphoblastic lymphoma in adults [PDF]
Cancer, 1981 Clinical and cytogenetic studied were done on 12 patients with lymphoblastic lymphoma. The ages of the patients ranged from 17 to 58 years (median, 24.5 years). Males predominated by a ration of 5:1. Ten of the 12 patients had a mediastinal mass at diagnosis; two thirds of the patients had involvement of the bone marrow (3 of 12 patients initially were
Yasuhiko Kaneko +5 more
openaire +3 more sources
Lymphoblastic lymphoma in two young siblings (coincidence or genetics?): two case reports
Journal of Medical Case Reports, 2021 Background Non-Hodgkin lymphoma is the fourth most common malignancy in children, and it is not considered to be a hereditary disorder. However, it could affect members from the same family.
Naya Talal Hassan +6 more
doaj +1 more source
Pathology and Oncology Research, 2023 Objective: Indolent T-lymphoblastic proliferation (iT-LBP) is a non-neoplastic disease with an indolent clinical course, manifesting as hyperplasia of immature extrathymic T-lymphoblastic cells.
Wen Han +5 more
doaj +1 more source
Lymphoblastic Lymphoma of the Palate [PDF]
Baylor University Medical Center Proceedings, 2017 Lymphoblastic lymphomas are neoplasms of immature or precursor lymphoid cells with no or limited bone marrow involvement, whose clinical presentation varies according to the immunophenotype. While mediastinal involvement is predominant in T-lymphoblastic lymphomas, B-lymphoblastic lymphomas frequently involve nodal sites.
Geetha Narayanan +3 more
openaire +3 more sources
Malignant lymphoma, lymphoblastic [PDF]
Cancer, 1976 Among the malignant lymphomas of the diffuse, poorly differentiated lymphocytic type, a cytologically distinctive form can be recognized. It is composed of immature lymphoid cells that are indistinguishable from the cells of acute lymphoblastic leukemia (ALL).
Hun Kim +2 more
openaire +2 more sources
FIP1L1‐PDGFRA fusion gene in T‐lymphoblastic lymphoma: A case report
Cancer Reports, 2023 Background T‐lymphoblastic lymphoma (T‐LBL) is an aggressive malignancy of T‐lymphoid precursors, rarely co‐occurring with myeloid/lymphoid neoplasms with eosinophilia (M/LNs‐Eo), with consequent rearrangement of tyrosine kinase (TK)‐related genes.
Salhah Ali +5 more
doaj +1 more source